Related references
Note: Only part of the references are listed.Iranian plant Eremurus persicus: an overview of botany, traditional uses, phytochemistry and pharmacology
Mohammad Beiranvand et al.
NATURAL PRODUCT RESEARCH (2022)
Repurposing mesalazine against cardiac fibrosis in vitro
Maximilian Hoffmann et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2021)
5-Aminosalicylic acid inhibits stem cell function in human adenoma-derived cells: implications for chemoprophylaxis in colorectal tumorigenesis
Steven William Dixon et al.
BRITISH JOURNAL OF CANCER (2021)
5-Aminosalicylic acid for treatment of irritable bowel syndrome A protocol for a systematic review and meta-analysis
Wenyuan Cheng et al.
MEDICINE (2020)
In vitro investigation of the effect of mesalazine on amyloid fibril formation of hen egg-white lysozyme and defibrillation lysozyme fibrils
Masoumeh Faramarzian et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Ulcerative colitis: understanding its cellular pathology could provide insights into novel therapies
Amandip Kaur et al.
JOURNAL OF INFLAMMATION-LONDON (2020)
The Protective Effect of 5-Aminosalicylic Acid against Non-Steroidal Anti-Inflammatory Drug-Induced Injury through Free Radical Scavenging in Small Intestinal Epithelial Cells
Eun Suk Jung et al.
MEDICINA-LITHUANIA (2020)
Ameliorating and protective effects mesalazine on ethanol-induced gastric ulcers in experimental rats
Mohammad Beiranvand et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Anti-Inflammatory Activity of Chitosan and 5-Amino Salicylic Acid Combinations in Experimental Colitis
Henusha D. Jhundoo et al.
PHARMACEUTICS (2020)
Editorial: mesalazine and mucosal microbiome in quiescent ulcerative colitis-what can we learn?
Anna M. Buchner et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
Conjugation of Amisulpride, an Anti-Psychotic Agent, with 5-Aminosalicylic Acid via an Azo Bond Yields an Orally Active Mutual Prodrug against Rat Colitis
Wooseong Kim et al.
PHARMACEUTICS (2019)
A review on 5-aminosalicylic acid colon-targeted oral drug delivery systems
Hossein Shahdadi Sardo et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
Improving the anti-inflammatory activity of 5-aminosalicylic acid by combination with cyanidin-3-glucoside: An in vitro study
Sonia R. Pereira et al.
JOURNAL OF FUNCTIONAL FOODS (2019)
Mucosal 5-aminosalicylic acid concentration, drug formulation and mucosal microbiome in patients with quiescent ulcerative colitis
Maya Olaisen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
Mesalamine and azathioprine modulate junctional complexes and restore epithelial barrier function in intestinal inflammation
Vineeta Khare et al.
SCIENTIFIC REPORTS (2019)
Comparison of Antioxidant and Anti-Inflammatory Effects of Honey and Spirulina platensis with Sulfasalazine and Mesalazine on Acetic Acid-Induced Ulcerative Colitis in Rats
Nadia Rezaei et al.
GALEN MEDICAL JOURNAL (2019)
5-Aminosalicylic Acid Modulates the Immune Response in Chronic Beryllium Disease Subjects
Brian J. Day et al.
LUNG (2018)
Systematic review: safety of mesalazine in ulcerative colitis
P. Sehgal et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Mesalazine, an osteopontin inhibitor: The potential prophylactic and remedial roles in induced liver fibrosis in rats
A. Ramadan et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2018)
Pluronic lecithin organogel of 5-aminosalicylic acid for wound healing
Bharat Kumar Reddy Sanapalli et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2018)
Neutropenia febril grave inducida por mesalazina
Mercedes Freire González et al.
MEDICINA CLINICA (2018)
Antibacterial ability of supported silver nanoparticles by functionalized hydroxyapatite with 5-aminosalicylic acid
Vesna Lazic et al.
VACUUM (2018)
Effect of intra-abdominally administered mesalazine (5-aminosalicylic acid) in experimental peritonitis
Aziz Sener et al.
NORTHERN CLINICS OF ISTANBUL (2018)
Effects of Mesalazine on Morphological and Functional Changes in the Indomethacin-Induced Inflammatory Bowel Disease (Rat Model of Crohn's Disease)
Higin Simon et al.
PATHOLOGY & ONCOLOGY RESEARCH (2017)
Oxidized 5-aminosalicylic acid activates Nrf2-HO-1 pathway by covalently binding to Keap1: Implication in anti-inflammatory actions of 5-aminosalicylic acid
Sookjin Kang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2017)
5-Aminosalicylic acid inhibits inflammatory responses by suppressing JNK and p38 activity in murine macrophages
Tingli Qu et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2017)
The effect of 5-aminosalicylic acid on renal ischemia-reperfusion injury in rats
Shokofeh Banaei
INDIAN JOURNAL OF PHARMACOLOGY (2016)
5-Aminosalicylates Reduce the Risk of Colorectal Neoplasia in Patients with Ulcerative Colitis: An Updated Meta-Analysis
Li-Na Zhao et al.
PLOS ONE (2014)
5-Aminosalicylic Acid attenuates allergen-induced airway inflammation and oxidative stress in asthma
K. Rama Satyanarayana Raju et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2014)
Randomised clinical trial: mesalazine (Salofalk granules) for uncomplicated diverticular disease of the colon a placebo-controlled study
W. Kruis et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Antioxidant Properties of Mesalamine in Colitis Inhibit Phosphoinositide 3-Kinase Signaling in Progenitor Cells
Elizabeth Managlia et al.
INFLAMMATORY BOWEL DISEASES (2013)
Mechanisms of Action of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Mesalazine in the Chemoprevention of Colorectal Cancer
Carmine Stolfi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Cr(III), Mn(II), Fe(III), Co(II), Ni(II), Cu(II) and Zn(II) new complexes of 5-aminosalicylic acid: Spectroscopic, thermal characterization and biological activity studies
Madiha H. Soliman et al.
SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY (2013)
Colorectal Cancer Chemoprevention by Mesalazine and Its Derivatives
Carmine Stolfi et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
Mesalazine (5-aminosalicylic acid) alters faecal bacterial profiles, but not mucosal proteolytic activity in diarrhoea-predominant irritable bowel syndrome
C. N. Andrews et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
MMX (R) Mesalazine A Review of its Use in the Management of Mild to Moderate Ulcerative Colitis
Lily P. H. Yang et al.
DRUGS (2011)
Optimizing clinical use of mesalazine (5-aminosalicylic acid) in inflammatory bowel disease
Chadwick Williams et al.
Therapeutic Advances in Gastroenterology (2011)
Scavenging of reactive oxygen and nitrogen species by the prodrug sulfasalazine and its metabolites 5-aminosalicylic acid and sulfapyridine
Diana Couto et al.
REDOX REPORT (2010)
Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study
R. Corinaldesi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Mesalazine inhibits the beta-catenin signalling pathway acting through the upregulation of mu-protocadherin gene in colo-rectal cancer cells
S. Parenti et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Inhibition of cell proliferation and invasion in a human colon cancer cell line by 5-aminosalicylic acid
Y. -H. Kim et al.
DIGESTIVE AND LIVER DISEASE (2009)
50 5-Aminosalicylic Acid Suppresses Colitis-Associated But Not Sporadic Colorectal Cancer
Pim J. Koelink et al.
GASTROENTEROLOGY (2009)
Effects of Mesalamine (5-Aminosalicylic Acid) on Bacterial Gene Expression
Jaime Kaufman et al.
INFLAMMATORY BOWEL DISEASES (2009)
Poly(ethylene glycol)-mesalazine conjugate for colon specific delivery
M. Canevari et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2009)
Oral administration of mesalazine protects against mucosal injury and permeation in dextran sulfate sodium-induced colitis in rats
Yoshihiro Hayashi et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2009)
Cyclooxygenase-2-dependent and -independent inhibition of proliferation of colon cancer cells by 5-aminosalicylic acid
Carmine Stolfi et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Prevention of complications and symptomatic recurrences in diverticular disease with mesalazine:: A 12-month follow-up
Giuseppe Comparato et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
Mesalazine downregulates c-Myc in human colon cancer cells. A key to its chemopreventive action?
E. C. Chu et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Continuous versus cyclic mesalazine therapy for patients affected by recurrent symptomatic uncomplicated diverticular disease of the colon
Antonio Tursi et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
Effectiveness of mesalamine and propolis in experimental colitis
Ahmet Aslan et al.
ADVANCES IN THERAPY (2007)
Free radical scavenging reactions of sulfasalazine, 5-aminosalicylic acid and sulfapyridine: Mechanistic aspects and antioxidant activity
R Joshi et al.
FREE RADICAL RESEARCH (2005)
Mesalamine promotes intestinal epithelial wound healing in vitro through a TGF-beta-independent mechanism
DC Baumgart et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2005)
Efficacy of mesalazine in the treatment of symptomatic diverticular disease
F Di Mario et al.
DIGESTIVE DISEASES AND SCIENCES (2005)
Review article: mechanisms of action of mesalazine in preventing colorectal carcinoma in inflammatory bowel disease
H Allgayer
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Share Paper
